Publications

Filter results by

List of Publications

Title Date PC3I Authors Journal
COVID-19 Exposure and Family Impact Scales for Adolescents and Young Adults April 23, 2022
PC3I Authors
Lisa A. Schwartz
Journal of Pediatric Psychology
Modifiable risk factors associated with long-term survival in women with serous ovarian cancer: a National Cancer Database study April 23, 2022
PC3I Authors
Anna Jo Smith
International Journal of Gynecological Cancer
COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer April 22, 2022
PC3I Authors
Charu Aggarwal
Journal of Clinical Oncology
Perspectives of State Association Leaders During the COVID-19 Pandemic April 20, 2022
PC3I Authors
George Demiris
American Journal of Hospice and Palliative Care
How Referring Providers Choose Specialists for Their Patients: a Systematic Review April 20, 2022
PC3I Authors
Shivan Mehta
Journal of General Internal Medicine
Policies and Practices to Address Cancer’s Long-Term Adverse Consequences April 19, 2022
PC3I Authors
Larry Shulman
Journal of the National Cancer Institute
Racial and Ethnic Disparities in Surgical Outcomes after Postmastectomy Breast Reconstruction April 15, 2022
PC3I Authors
Oluwadamilola "Lola" Fayanju
Journal of the American College of Surgeons
Gaps in completion and timeliness of breast surgery and adjuvant therapy: a retrospective cohort of Haitian patients with nonmetastatic breast cancer April 14, 2022
PC3I Authors
Larry Shulman
Breast Cancer Research and Treatment
Cancer-related inflammation and depressive symptoms: Systematic review and meta-analysis April 13, 2022
PC3I Authors
Meredith Doherty
Cancer
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial April 13, 2022
PC3I Authors
Charu Aggarwal
Journal for Immunotherapy of Cancer
Oncology alternative payment models: lessons from commercial insurance April 11, 2022
PC3I Authors
AJMC
A Veteran-Centric Web-Based Decision Aid for Lung Cancer Screening: Usability Analysis April 8, 2022
PC3I Authors
Anil Vachani
JMIR Formative Research
Phase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non-squamous Non-small Cell Lung Cancer After Progression on Platinum and Pemetrexed April 8, 2022
PC3I Authors
Charu Aggarwal; Melina Marmarelis; Christopher A. D’Avella
Clinical Lung Cancer
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study April 8, 2022
PC3I Authors
Charu Aggarwal; Melina Marmarelis; Christopher A. D’Avella; Anil Vachani
JTO Clinical and Research Reports
Intensity of end-of-life care for gynecologic cancer patients by primary oncologist specialty April 5, 2022
PC3I Authors
Emily Ko
International Journal of Gynecological Cancer
Oncologist Peer Comparisons as a Behavioral Science Strategy to Improve Hospice Utilization April 4, 2022
PC3I Authors
Ramy Sedhom; Larry Shulman
JCO Oncology Practice
Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana April 3, 2022
PC3I Authors
Surbhi Grover
BMC Women's Health
Cancer research collaboration between the UK and the USA: reflections on the 2021 G20 Summit announcement March 31, 2022
PC3I Authors
Larry Shulman
The Lancet. Oncology
An Assistive Electronic Patient-Reported Outcome Monitoring Intervention for Management of Immune-Related Toxic Effects-Moving Toward Efficiency and Scale March 31, 2022
PC3I Authors
Samuel Takvorian
JAMA Network Open
Photodynamic therapy for stage I and II non-small cell lung cancer: A SEER-Medicare analysis 2000-2016 March 31, 2022
PC3I Authors
Anil Vachani
Medicine (Baltimore)